Tevogen Peports Plans to Increase the Target Population for TVGN 489

finance.yahoo.com/news/tevogen-peports-plans-increase-target-221921997.html

In This Article:
Tevogen Bio Holdings Inc. (NASDAQ:TVGN) revealed plans to broaden the scope of its TVGN 489 experimental medication to encompass patients 65 years of age and above.
A laboratory technician researching a sample of cells in a biotechnology laboratory.
The action expands…

This story appeared on finance.yahoo.com, 2025-05-25 22:19:21.
The Entire Business World on a Single Page. Free to Use →